Embelin possessed neuroprotective and anti-AD effects that could be mediated by synaptic plasticity, antioxidant, anti-inflammatory, APP and Mapt gene response, cholinergic activity, neurochemical modulation and BDNF-CREB pathway. This evidence concerns the gene CREB1 and Alzheimer disease.